Gyre Therapeutics Inc. (GYRE)
US$ 15.321.73%
Price Chart
Key Statistics
Market Cap
$ 893.37M
P/E Ratio
190.60
Revenue (TTM)
$ 100.64M
Volume
34.81K
52W High
$ 19.00
52W Low
$ 6.11
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
9.2528
200-Day MA
11.6028
52 Week High
19
52 Week Low
6.11
About GYRE
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
Employees
579
Headquarters
San Diego, CA
CEO
Dr. Han Ying Ph.D.
Latest News
Gyre could jump-start tropical activity ahead of hurricane season - AccuWeather
6 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg